Respiratory News and Research

RSS

Experimental vaccine protects against fentanyl and related opioids

Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses, the drugs hijack brain chemistry and shut down the signals that control breathing.

11 Jun 2026

Leading AI models ace many vaccine questions but falter on clinical rules

A multilingual benchmark of 1,886 vaccine-related questions found that large language models answered most items accurately across English, Spanish, and Chinese. However, performance varied by vaccine type, language, and prompting method, with persistent errors in dosing, contraindications, age eligibility, and other clinically sensitive guidance.

11 Jun 2026

Trial finds prunes do not outperform calcium and vitamin D for male bone density

A one-year randomized trial found that daily prune supplementation did not improve total or lumbar spine bone mineral density in older men susceptible to, or with, osteopenia. Although some bone turnover biomarkers differed between prune and control groups, these changes did not translate into measurable bone density benefits beyond calcium and vitamin D3 supplementation.

11 Jun 2026

Remote monitoring does not beat usual care for sepsis patients

Remote monitoring isn't a panacea for reducing readmissions across all conditions - and for some patients, clinicians should proceed with caution, clinical trial results published today in JAMA Network Open suggest.

11 Jun 2026

New treatment platform delivers full-length mRNA for Duchenne muscular dystrophy

A new treatment platform developed by researchers at The University of Texas MD Anderson Cancer Center was able to deliver messenger RNA (mRNA) of the full-length DMD gene into preclinical models of Duchenne muscular dystrophy, successfully restoring the production of an important muscle protein, dystrophin, and dramatically improving muscle strength, endurance and function in vivo.

11 Jun 2026

Researchers identify genetic cause of severe childhood lung disease

A new report in the American Journal of Human Genetics describes a novel disorder caused by biallelic loss-of-function variants in the TMEM63B gene, which results in severe lung disease.

10 Jun 2026

Remote work explains part of the post-pandemic rise in mental distress

Researchers found that workers in remote jobs spent more time alone after the COVID-19 pandemic and experienced greater psychological distress than those in non-remote jobs. The effects were strongest among people living alone, suggesting that reduced everyday social contact may be an important cost of remote work.

10 Jun 2026

GSV hospitals achieve substantially higher delirium screening in older surgical patients

There is a stark gap in how often hospitals screen older adults for postoperative delirium, with verified geriatric surgery programs screening nearly every patient while non-accredited programs screen just half, according to new findings published in the Journal of the American College of Surgeons.

10 Jun 2026

Why Andes hantavirus is not the next COVID-19

Research highlights fundamental differences between Andes hantavirus and SARS-CoV-2, emphasizing distinct transmission routes and public health implications.

10 Jun 2026

Oral swab detects hidden inflammation in rare lung disease

Researchers at UTHealth Houston have identified different types of hidden systemic inflammation in patients with primary ciliary dyskinesia, even when they are not experiencing acute illness.

9 Jun 2026

NHS pathology staff face unsafe formaldehyde exposure levels

Routine exposure to harmful levels of the human tissue preservative formaldehyde are risking the health of thousands of NHS staff working in pathology departments across the UK, due to poor monitoring and control, finds an analysis of Freedom of Information (FOI) requests, published online in the journal Occupational & Environmental Medicine.

9 Jun 2026

Experimental two‑in‑one vaccine shows success in human LASSARAB trial

Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.

9 Jun 2026

New genetic disorder linked to severe childhood lung disease

A new report in the American Journal of Human Genetics describes a novel disorder caused by biallelic loss-of-function variants in the TMEM63B gene, which results in severe lung disease.

8 Jun 2026

Infections pose major but overlooked risks in people with diabetes

Infections should be considered a "health hazard" in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but under-recognized burden of illness, hospitalization and death.

7 Jun 2026

Maternal vaccination provides protection against RSV-associated hospitalization in early infancy

A study led by researchers at the University of Pittsburgh and UPMC published today in JAMA Network Open, a peer-reviewed journal of the American Medical Association, found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in young infants by nearly 70%.

5 Jun 2026

Global decline in child mortality slowed down significantly since 2015

Global progress in reducing preventable deaths among newborn babies, children, and adolescents has slowed substantially since 2015, and many countries risk missing international child survival targets by 2030, find a series of papers published by The BMJ today.

4 Jun 2026

CIC biomaGUNE develops pulmonary surfactant nanoparticles to treat lung diseases

The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that lines the alveoli and enables breathing), which are encapsulated in a drug used to treat pulmonary fibrosis.

4 Jun 2026